Drug Topics

JULY 9, 2024

Researchers are evaluating the safety, tolerability, and immunogenicity of shingles vaccine candidate Z-1018.

Vaccines 376

Vaccines 376

PharmaVoice

JULY 9, 2024

Vetigenics believes it’s found a way to make pricey antibody-based technologies more accessible for animals.

279

279

Drug Topics

JULY 9, 2024

Previously, data from head-to-head trials of tirzepatide and semaglutide were not available.

281

281

Pharmacy Times

JULY 9, 2024

In a new report, the FTC says pharmacy benefit managers act as middlemen in the pharmaceutical industry, leading to the squeezing of independent pharmacies and increases in prices for patients.

Independent Pharmacies 149

Independent Pharmacies 149

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

JULY 9, 2024

The FTC released its interim report detailing PBM practices, staggering market consolidation statistics, and the disparities between PBMs and their smaller competitors.

281

281

STAT

JULY 9, 2024

STAT is co-publishing this investigation by Undark. They numbered 20 in all — 10 men and 10 women who came to a sprawling medical campus in downtown Buffalo, N.Y., to volunteer for what a news report had billed as “the world’s biggest science project.

145

145

STAT

JULY 9, 2024

In stark terms, the Federal Trade Commission found in a report released Tuesday that pharmacy benefit managers — the opaque middlemen in the pharmaceutical supply chain — wield such “enormous power” that these companies can affect the ability of many Americans to access and afford their medicines. The agency noted that the three largest PBMs processed nearly 80% of the roughly 6.6 billion prescriptions dispensed by U.S. pharmacies in 2023.

Independent Pharmacies 145

Independent Pharmacies Insurance 145

Drug Topics

JULY 9, 2024

McKesson’s private brand of OTC health and wellness products are a great way for independent pharmacies to increase profits.

Independent Pharmacies 216

Independent Pharmacies 216

Pharmacy Times

JULY 9, 2024

Daily multivitamin users were associated with a 4% higher mortality risk compared to nonusers.

145

145

STAT

JULY 9, 2024

The overdose crisis is claiming lives across the United States, but it reaches new depths of despair in the criminal justice system. Overdose is the leading cause of death among people returning to their communities after being in jail or prison. Providing addiction treatment in these settings could change that. Roughly 60% of people who are incarcerated have a substance use disorder, in many cases an opioid use disorder.

139

139

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Healthcare

JULY 9, 2024

OpenAI's venture fund and Arianna Huffington's Thrive Global are backing a new startup, Thrive AI Health, that aims to build an AI health coach to promote healthier lifestyles. | OpenAI's venture fund and Arianna Huffington's Thrive Global are backing a new startup that aims to build an AI health coach to promote healthier lifestyles.

133

133

STAT

JULY 9, 2024

Five years ago — before the pandemic — Pfizer’s head of research and development, Mikael Dolsten, told STAT he kept a chess set in his office that he got as a gift from a former CEO of the company. It was a memento delivered to Dolsten after he cautioned his boss that research and development was a long process, like a chess match, not something that would happen quickly.

135

135

PharmaVoice

JULY 9, 2024

Recent history suggests an Alzheimer’s approval doesn’t necessarily translate to market triumph. Perhaps for Eli Lilly’s Kisunla, this time could be different.

FDA 130

FDA 130

STAT

JULY 9, 2024

The Human Genome Project was among the most ambitious scientific efforts in modern history, with the aim of deciphering the chemical makeup of the entire human genetic code. The sequence of some 3 billion DNA base pairs that comprise our genome was supposed to be a mosaic, assembled from multiple anonymous people to protect the identity of the volunteer donors.

130

130

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Healthcare

JULY 9, 2024

Pharmacy benefit managers (PBMs) have vast power and scale that disadvantages consumers and independent pharmacies, a new report from the Federal Trade Commission argues. | The FTC turned its attention toward pharmacy benefit managers in a new report detailing the consequences of consolidation and vertical integration, warning legal action and regulation could follow.

Independent Pharmacies 124

Independent Pharmacies 124

STAT

JULY 9, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning. STAT published an investigation this morning on the untold story of the Human Genome Project and ethics concerns surrounding the ambitious project. Check it out  here.

FDA 120

FDA 120

pharmaphorum

JULY 9, 2024

Learn about the opportunity costs of gene therapies like Beqvez. Discover the obstacles and potential paths forward in the evolving field of gene therapy.

118

118

The Checkup by Singlecare

JULY 9, 2024

Polycystic ovary syndrome (PCOS) is a common women’s health condition caused by an imbalance of reproductive hormones. It results in problems such as irregular, heavy periods, decreased fertility, acne, and unwanted hair growth. If you have PCOS, your healthcare provider might recommend using hormonal birth control like the combination pill, patch, or intrauterine device (IUD) to help manage symptoms of PCOS.

111

111

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

pharmaphorum

JULY 9, 2024

A long-awaited report from the US Federal Trade Commission (FTC) on pharmacy benefit managers (PBMs) is out – and will make uncomfortable reading for the pharma supply chain middlemen.Its central message is clear. The six largest PBMs in the US manage nearly 95% of all prescriptions filled in the US, a “concentrated market structure” that has allowed them to “profit at the expense of patients and independent pharmacists,” according to the financial regulator.

Prescription Filling 113

Prescription Filling 113

Pharmacy Times

JULY 9, 2024

The authors note that the oral, at-home treatment can a better alternative for patients by reducing inconveniences that come with the injectable and nasal administration methods.

107

107

pharmaphorum

JULY 9, 2024

After languishing in the doldrums for a few quarters, there are signs that the winds of investment are starting to blow again in the US digital health sector.

111

111

Pharmacy Times

JULY 9, 2024

Higher vaccination rates were associated with less prevalent asthmatic symptoms, but additional research is needed to confirm these findings.

Vaccines 107

Vaccines 107

pharmaphorum

JULY 9, 2024

Mikael Dolsten exits Pfizer, putting R&D leadership in flux Phil.

110

110

STAT

JULY 9, 2024

Neurological diseases are now the leading cause of poor health and disability worldwide. An estimated 3.4 billion people, or 40% of the world’s population, are affected by neurological disorders such as Alzheimer’s disease and other dementias, stroke, migraine, depression, anxiety, neonatal encephalopathy, and more. Efforts to expand research that can lead to new and more effective treatments for neurological diseases are sorely needed.

105

105

European Pharmaceutical Review

JULY 9, 2024

Researchers have developed an ultrasensitive analytical method for quantifying nitrite quantity in process water for pharmaceutical products. The team tested various samples two ion chromatography analytical methods. This included a range of water types eg, purified and potable water, according to the paper. Kumar et al. explained that “accurate determination of nitrite content in process water will support an understanding of the potential for nitrosamine formation from nitrite in process water

Dosage 105

Dosage 105

pharmaphorum

JULY 9, 2024

Roche will reintroduce its Susvimo implant wet AMD, which was withdrawn from sale in 2022 due to manufacturing defects.

105

105

Pharmaceutical Commerce

JULY 9, 2024

The latest news for pharma industry insiders.

102

102

pharmaphorum

JULY 9, 2024

In this latest pharmaphorum podcast, web editor Nicole Raleigh speaks with Michael Kyle, chief medical officer at Currax Pharmaceuticals – a company working to advance a greater understanding of how to effectively treat obesity – about perceptions and options beyond the bounds of GLP-1s, including evolution of hypertension treatments.

102

102

Pharmacy Times

JULY 9, 2024

Individuals with tattoos were found to have a greater risk of developing malignant lymphoma, with the risk being highest within 2 years of receiving a tattoo.

101

101

STAT

JULY 9, 2024

WASHINGTON — A Massachusetts man has regained his voice after surgeons removed his cancerous larynx and, in a pioneering move, replaced it with a donated one. Transplants of the so-called voice box are extremely rare, and normally aren’t an option for people with active cancer. Marty Kedian is only the third person in the U.S. ever to undergo a total larynx transplant – the others, years ago, because of injuries – and one of a handful reported worldwide.

97

97

Fierce Healthcare

JULY 9, 2024

Staff shortages in healthcare can be alleviated by the use of artificial intelligence but workers are often reluctant and skeptical about its use. | Most healthcare executives agree that using technology to automate repetitive tasks or processes is critical for addressing staff shortages in healthcare. But, nearly two-thirds say healthcare professionals are skeptical about the use of AI and automation technology.

97

97

The Checkup by Singlecare

JULY 9, 2024

Lithium is a generic prescription drug approved by the Food and Drug Administration (FDA) for people ages 7 years and older for the treatment and prevention of manic episodes associated with bipolar I disorder—a mental health condition characterized by episodes of intense mood swings. It’s a relatively low-cost maintenance treatment that has been around for a long time, according to psychiatrist Sid Khurana, MD, the medical director and co-founder of Nevada Mental Health.

Dosage 95

Dosage FDA Insurance 95

Pharmacy Times

JULY 9, 2024

The drug is intended to treat individuals with metastatic or locally advanced melanoma.

FDA 93

FDA 93